[1]
S. Ogata-Suetsugu, N. Hamada, K. Takayama, K. Tsubouchi, M. Arimura-Omori, and Y. Nakanishi, “The clinical value of serum soluble interleukin-2 receptor in pulmonary sarcoidosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 34, no. 1, pp. 41–47, Apr. 2017, doi: 10.36141/svdld.v34i1.5045.